The Inhibitory Effect of Rosiglitazone on Agonist-Induced or Spontaneous Regulation of Contractility

다국어 초록 (Multilingual Abstract)

The present study was undertaken to determine whether rosiglitazone treatment influences on the agonist-induced or spontaneous regulation of vascular smooth muscle contraction and, if so, to investigate the related mechanism. Stimulants were directly added without any preanesthetic stress or spontaneous vasoconstriction was induced by preanesthetic physical stress where rat aortic ring preparations isolated from rat exposed to preanesthetic stress such as pinch or prick for 30 min were mounted in organ baths and then exposed to contractile agents.
Previously and subchronically ingested rosiglitazone decreased Rho-kinase activating agonistinduced contraction but not depolarization- or α adrenergic agonist-induced contraction. Moreover, preanesthetic stress induced the stress-induced spontaneous contraction and previously and subchronically ingested rosiglitazone abolished the stress-induced spontaneous contraction.
In conclusion, this study provides the evidence and possible related mechanism concerning the vasorelaxing effect of an antidiabetic rosiglitazone as an antihypertensive on the agonist-induced contraction or stress-induced spontaneous vasoconstriction in rat aortic rings regardless of endothelial function.

참고문헌 (Reference)

1 "α1-Adrenergic signaling mechanisms in contraction of resistance arteries" 150 : 91-139, 2003

2 "Thromboxane A 2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca 2+ entry and Ca 2+ sensitization"

3 "Thiazolidinedione derivatives in type 2 diabetes mellitus" 64 : 166-174, 2006

4 "The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker faty rats" 48 : 1448-1453, 1999

5 "Stress, anxiety and cardiovascular disease: an interdisciplinary approach" 15 : 21-31, 2004

6 "Signal transduction and regulation in smooth muscle. Nature" 231-236, 1994

7 "Roles for G(12)/ G(13) in agonist-induced vascular smooth muscle cell contraction" 87 : 221-227, 2000

8 "Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho" 15 : 2208-2216, 1996

9 "Protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A." 9307-9310, 1991

10 "Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats" 66 : 150-161, 2005

11 "Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells" 83 : 1097-1103, 1998

12 "PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expresion: PPAR- gamma as a potential mediator in vascular disease" 19 : 546-551, 1999

13 "From pharmacomechanical coupling to G- proteins and myosin phosphatase" 164 : 437-448, 1998

14 "Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects" 29 : 581-587, 2006

15 "Cardiovascular, hormone, and lipid responses to stress induced by virtual crane handling" 18 : 357-365, 2005

16 "Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension" 389 : 990-994, 1997

17 "Ca 2+-dependent activation of Rho and Rho-kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle con- traction" 93 : 548-556, 2003

18 "Activation of MAP kinases and phosphorylation of caldesmon in canine colonic smooth muscle" 495 : 597-609, 1996

19 "A role for Rho kinase in vascular contraction evoked by sodium fluoride" 343 : 27-33, 2006

20 "A novel serine/ threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes" 270 : 29051-29054, 1995